Telo Genomics Corp. (TSXV:TELO)

Canada · Delayed Price · Currency is CAD

0.0700

+0.0200 (40.00%)

Oct 9, 2026, 1:48 PM EST

Telo Genomics Financials Overview

Financials in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Gross Profit	-	-	-	-	-	-
Operating Income	-2.24	-2.7	-2.72	-2.82	-2.11	-1.25
Net Income	-2.34	-2.72	-2.71	-2.82	-2.11	-1.07
Earnings Per Share	-0.02	-0.03	-0.04	-0.05	-0.04	-0.02
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Investments	0.98	0.79	0.8	2.67	2.69	3.64
Total Debt	1.32	-	-	0.03	0.04	0.04
Net Cash (Debt)	-0.34	0.79	0.8	2.64	2.65	3.6
Net Cash Growth	-	-0.84%	-69.86%	-0.46%	-26.24%	308.24%
Net Cash Per Share	-0.00	0.01	0.01	0.04	0.05	0.08

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Cash Flow	-1.3	-2.33	-2.46	-2.63	-1.79	-1.1
Capital Expenditures	-0.02	-0	-0.01	-0.07	-0.03	-0.01
Free Cash Flow	-1.32	-2.33	-2.46	-2.7	-1.82	-1.11
Free Cash Flow Growth	-	-	-	-	-	-

Valuation

Selected indicators aren't available for this stock.